Small ubiquitin-like modifier protein-specific protease 1 and prostate cancer

Asian Journal of Andrology

Volumn 11, Issue 1, 2009, Pages 36-38

  Zuo, Yong ^a   Cheng, Jin Ke ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SUMO 1 PROTEIN; SUMO 1 SPECIFIC PROTEASE 1 PROTEIN; UNCLASSIFIED DRUG; HIF1A PROTEIN, HUMAN; PROTEINASE; SENP1 PROTEIN, HUMAN; SUMO1 PROTEIN, HUMAN;

CARCINOGENESIS; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; SUMOYLATION; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTATE TUMOR;

ENDOPEPTIDASES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; SUMO-1 PROTEIN;

EID: 69449090864     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2008.45     Document Type: Review

References (16)

1. Geiss-Friedlander R, Melchior F. Concepts in sumoylation: A decade on. Nat Rev Mol Cell Biol 2007; 8: 947-56.
2. Hay RT. SUMO: A history of modification. Mol Cell 2005; 18: 1-12.
3. Yeh ET, Gong L, Kamitani T. Ubiquitin-like proteins: New wines in new bottles. Gene 2000; 248: 1-14.
4. Hay RT. SUMO-specific proteases: A twist in the tail. Trends Cell Biol 2007; 17: 370-6.
5. Mukhopadhyay D, Dasso M. Modification in reverse: The SUMO proteases. Trends Biochem Sci 2007; 32: 286-95.
6. Cheng J, Kang X, Zhang S, Yeh ET. SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell 2007; 131: 584-95.
7. Gelmann EP. Molecular biology of the androgen receptor. J Clin Oncol 2002; 20: 3001-15.
8. Shang Y, Myers M, Brown M. Formation of the androgen receptor transcription complex. Mol Cell 2002; 9: 601-10.
9. Cheng J, Wang D, Wang Z, Yeh ET. SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1. Mol Cell Biol 2004; 24: 6021-8.
10. Cheng J, Bawa T, Lee P, Gong L, Yeh ET, et al. Role of desumoylation in the development of prostate cancer. Neoplasia 2006; 8: 667-76.
11. Bawa-Khalfe T, Cheng J, Wang Z, Yeh ET. Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells. J Biol Chem 2007; 282: 37341-9.
12. Debes JD, Tindall DJ. The role of androgens and the androgen receptor in prostate cancer. Cancer Lett 2002; 187: 1-7.
13. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-4.
14. Huang LE, Gu J, Schau M, Bunn HF. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 1998; 95: 7987-92.
15. Ivan M, Kondo K, Yang H, Kim W, Valiando J, et al. HIF alpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001; 292: 464-8.
16. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-5.